Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Organigram Global Inc.NASDAQ: OGI

Depreciation & Amortization · Q2 FY2026 · quarter ended Mar 2026

Depreciation & amortization grows, but more slowly than its trailing trend

Q2 FY2026 depreciation & amortization of CA$5.03M rose 4.0% year over year, behind the +37.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.1% from the prior quarter.

Context

  • Depreciation & amortization amounted to 6.9% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +4.0% toward the trailing-twelve-month pace of +37.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$5.03M+1.1% QoQ
Last fiscal yearSep 2025
CA$12.91M+6.8% YoY
LTMMar 2026
CA$19.76M+37.8% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.0%——
1 year+6.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

CAD · from the income statement

Latest · FY2025
12.91M CAD
Year-over-year change
+6.8%
4-year CAGR
-19.7%

Depreciation & Amortization vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +37.8% is the 2nd highest of 9, against a peer median of +9.6%.
  • Depreciation & amortization amounts to 7.2% of revenue for OGI, versus a peer median of 7.0%.
OGI Competitors
Depreciation & Amortization for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OGIOrganigram Global Inc.LTM Mar 2026CA$19.76M CAD+37.8%—7.2%
ACBAurora Cannabis Inc.LTM Mar 2026CA$13.44M CAD-40.4%-35.3%4.3%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$13.23M USD+2.4%-0.2%9.3%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$9.77M USD—-23.7%7.2%
DERMJourney Medical CorporationLTM Mar 2026$4.39M USD+16.5%-0.1%6.8%
IVAInventiva S.A.FY2025€2.8M EUR-46.2%+47.6%62.4%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$2.42M USD+13.8%+13.3%136.2%
ELMDElectromed, Inc.LTM Mar 2026$1.2M USD+21.9%+23.1%1.7%
HSDTSolana CompanyLTM Mar 2026$672K USD+1192.3%+38.7%7.0%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$334K USD+5.4%+13.8%1.0%
Peer median (excluding OGI) —+9.6%+13.3%7.0%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.